Law offices of howard g. smith encourages revance therapeutics, inc. (rvnc) investors to inquire about securities fraud class action

Bensalem, pa.--(business wire)--law offices of howard g. smith announces that a class action lawsuit has been filed on behalf of investors who purchased revance therapeutics, inc. (“revance” or the “company”) (nasdaq: rvnc) securities between february 29, 2024 and december 6, 2024, inclusive (the “class period”). revance investors have until march 4, 2025 to file a lead plaintiff motion. if you are an investor who suffered a loss in revance therapeutics, inc. (rvnc), contact the law offices of.
RVNC Ratings Summary
RVNC Quant Ranking